Bloomberg Law’s combination of innovative analytics, research tools and practical guidance provides you with everything you need to be a successful litigator.
May 2 — Monsanto won a partial victory in litigation over its Roundup herbicide when the Southern District of California ruled April 29 that some product liability claims of a cancer-stricken turf installer must be dismissed.
The ruling tossed Emanuel Giglio's negligent misrepresentation and express warranty claims as insufficiently pleaded, but allowed other product liability claims to proceed.
Giglio, who owned and operated a turf installation business, claims his exposure to Roundup caused his non-Hodgkin's Lymphoma. His case is one of several California cases filed over the safety of the product (30 TXLR 1143, 12/3/15).
Monsanto contended Giglio's failure-to-warn claims are preempted by federal law because Roundup labels are registered under the Federal Insecticide, Fungicide, and Rodenticide Act, 7 U.S.C. §136 et seq.
The court agreed that FIFRA preempted Giglio's claim of a failure to warn the EPA about the dangers of a glyphosate—an ingredient of Roundup—but said the preemption argument only goes so far.
The complaint also states a consumer misbranding claim that doesn't implicate a labeling requirement “in addition to or different from” those required by FIFRA, the court said.
Monsanto's related argument—that Roundup isn't carcinogenic and that the EPA agrees—requires additional fact-finding, the U.S. District Court for the Southern District of California said.
The same was true of Giglio's design defect claim, which requires a product-by-product assessment under the Restatement (Second) of Torts to determine a pesticide's “value to society relative to the harm it causes,” the court said.
Chief Judge Barry Ted Moskowitz wrote the opinion.
The law offices of Andrus Wagstaff represented Emanuel R. Giglio.
Parker, Milliken, Clark, O'Hara & Samuelian, as well as Hollingsworth represented Monsanto Co.
To contact the reporter on this story: Steven M. Sellers in Washington at firstname.lastname@example.org.
The opinion is available at http://www.bloomberglaw.com/public/document/Giglio_v_Monsanto_Co_No_15cv2279_BTMNLS_2016_BL_137680_SD_Cal_Apr.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)